Fairvoy Private Wealth’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$476K Sell
2,044
-145
-7% -$33.5K 0.1% 138
2026
Q2
$464K Sell
2,189
-455
-17% -$89.3K 0.09% 142
2026
Q1
$518K Sell
2,644
-118
-4% -$22.9K 0.12% 140
2025
Q4
$479K Buy
2,762
+718
+35% +$131K 0.11% 120
2025
Q3
$390K Buy
+2,044
New +$363K 0.09% 140

Other funds holding DGX

Fairvoy Private Wealth's DGX Position: Q3 2026 in Review

Fairvoy Private Wealth reduced its Quest Diagnostics (DGX) stake by 6.6% in Q3 2026, selling an estimated $33.5K and leaving 2,044 shares worth $476K. The position accounts for 0.1% of the portfolio, ranked #138.

Fairvoy Private Wealth first reported a position in DGX in Q3 2025 and has held it in 5 quarters since. The position peaked at $518K in Q1 2026. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Fairvoy Private Wealth held 2,044 shares of Quest Diagnostics worth $476K as of Q3 2026.
  • Fairvoy Private Wealth sold 145 Quest Diagnostics shares in Q3 2026, an estimated $33.5K.
  • Quest Diagnostics made up 0.1% of Fairvoy Private Wealth's portfolio in Q3 2026, its #138 holding.
  • Fairvoy Private Wealth first reported a position in Quest Diagnostics in Q3 2025 and has held it in 5 quarters since.
  • Fairvoy Private Wealth's Quest Diagnostics position peaked at $518K in Q1 2026.
  • 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Fairvoy Private Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.